Significance of immune function indicators in the clinical examination of children with neuroblastoma

JIAO Hong; KONG Xiaohui; ZHANG Hui; GUI Jingang

PDF(962 KB)

Medical Journal of the Chinese People Armed Police Forces ›› 2026, Vol. 37 ›› Issue (4) : 301-305.

ORIGINAL ARTICLES

Significance of immune function indicators in the clinical examination of children with neuroblastoma

JIAO Hong,KONG Xiaohui,ZHANG Hui, GUI Jingang

Author information +

History +

Abstract

Objective To explore the significance of immune function indicators in the clinical examination of children with neuroblastoma (NB). Methods The clinical data of 393 pediatric patients with NB (199 males, 194 females) treated at Beijing Children's Hospital Affiliated to Capital Medical University from 2018 to 2023 were retrospectively analyzed, while 67 normal healthy children (38 males, 29 females)who underwent physical examinations during the same period were selected as the control group. At initial evaluation, serum immunoglobulins (IgG, IgA, IgM) and total IgE were compared between the two groups. Through cellular immunity in blood and flow cytometry, the levels of peripheral blood T lymphocytes (CD3⁺, CD4⁺, CD8⁺, CD4⁺/CD8⁺), B cells (CD19⁺), and natural killer (NK) cells (CD16⁺CD56⁺) were detected. Results NB predominantly affected children aged 0-3 years (n=208 in this cohort). Compared with healthy controls, children with NB had significantly lower levels of CD3⁺, CD4⁺, and CD4⁺/CD8⁺, and significantly higher levels of CD8⁺ and NK cells, with statistically significant differences between the two groups (P<0.05). No significant difference was observed in the level of B cells (Z=-1.909, P=0.056). The levels of IgG, IgA, and IgE were significantly higher in the NB group than i those in the control group, and the differences were statistically significant(P<0.05), whereas the level of IgM showed no significant difference. Conclusions Pediatric NB is associated with dysregulation of both cellular and humoral immunity. Monitoring the levels of lymphocyte subsets and Ig series in children may facilitate the evaluation of the cellular and humoral immune functions of the affected children.

Key words

pediatric neuroblastoma / peak age of onset / T-lymphocytes / immunoglobulin

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

JIAO Hong,KONG Xiaohui,ZHANG Hui, GUI Jingang. Significance of immune function indicators in the clinical examination of children with neuroblastoma[J]. Medical Journal of the Chinese People Armed Police Forces. 2026, 37(4): 301-305

References

[1] 中国抗癌协会小儿肿瘤专业委员会, 中华医学会小儿外科学分会肿瘤外科学组. 儿童神经母细胞瘤诊疗专家共识[J]. 中华小儿外科杂志,2015,36(1):3-7.
[2] 夏剑锋, 张倩, 梅海. 儿童神经母细胞瘤临床诊疗的研究进展[J]. 肿瘤医学综述,2020,26(4):690-693.
[3] 孙宁, 郑珊. 小儿外科学[M]. 北京:人民卫生出版社,2015:253-260.
[4] Swift C C, Eklund M J, Kraveka J M, et al. Updates in diagnosis, management, and treatment of neuroblastoma[J]. Radiographics, 2018, 38(2): 566-580.
[5] Shi Q, Yu B, Zhang Y, et al. Feng haizhong targeting TRIM24 promotes neuroblastoma differentiation and decreases tumorigenicity via LSD1/CoREST complex[J].Cellular oncology (Dordrecht),2023,11:1763-1775.
[6] 唐威,陈开澜,聂应明,等.单中心60例高危儿童神经母细胞瘤临床疗效及预后分析[J].临床儿科杂志,2024,42(10):881-887.
[7] 刘涛,盛庆丰.INSS 4期神经母细胞瘤患儿3年无事件生存率的相关因素分析[J].临床小儿外科杂志,2022,21(2):121-127.
[8] 郝增辉,王龙,李超. 基于TARGET数据库的儿童神经母细胞瘤总体生存率影响因素研究[J].哈尔滨医科大学学报,2020,54(5):523-526.
[9] Pudela C, Balyasny S, Applebaum M A. Nervous system: embryonal tumors: neuroblastoma[J]. Atlas Genet Cytogenet Oncol Haematol, 2020, 24(7): 284-290.
[10] 朱呈光, 贺湘玲, 汤止戈,等. 44例儿童神经母细胞瘤临床分析[J]. 中国当代儿科杂志,2020,22(11):1193-1197.
[11] Van H J, Kruger M. Management of neuroblastoma in limited-resource settings[J]. World J Clin Oncol, 2020, 11(8): 629-643.
[12] 刘梦捷,傅毅立,汪京,等. 术前炎症生物标志物对预测肺腺癌患者微波消融术后长期预后的价值[J]. 武警医学,2025,36(3):208-213.
[13] Zheng X, Qian Y, Fu B, et al. Mitochondrial fragmentation limits NK cell-based tumor immunosurveillance[J]. Nat Immunol, 2019, 20(12): 1656-1667.
[14] 罗欣怡,刘宝瑞.记忆性NK细胞在肿瘤免疫治疗研究和应用进展[J].中国肿瘤生物治疗杂志,2025,32(5):531-537.
[15] 王莉新,吴文斌. NK细胞的免疫监视作用及肿瘤免疫逃逸 [J] 细胞与分子免疫学杂志,2017,33(3):418-422.
[16] Zhang B, Liu J, Mo Y, et al. CD8⁺ T cell exhaustion and its regulatory mechanisms in the tumor microenvironment: key to the success of immunotherapy[J]. Front Immunol, 2024, 15: 1476904.
[17] Jia H, Yang H, Xiong H, et al. NK cell exhaustion in the tumor microenvironment[J]. Front Immunol, 2023, 14: 1303605.
[18] Otte J, Dyberg C, Pepich A, et al. MYCN function in neuroblastoma development [J]. Front Oncol,2021,10:624079.
[19] 李东晓,卢世栋,胡晓,等. COVID-19确诊病例及灭活疫苗接种者不同时期血清IgA,IgM,IgG抗体检测结果比较 [J].中国公共卫生,2023,39(9)1159-1164.
[20] Zhao Y,Aldoss I,Qu C, et al.Tumor-intrinsic and -extrinsic determinants of response to blinatumomab in adults with B-ALL[J].The J of the Ameri Soc of Hem,2021,137(4):471-484.
[21] 李远波,张华.肺炎支原体肺炎患者血清IgG,IgM,IL-2,TNF-α的水平变化及临床意义[J].检验医学与临床,2020,17(24): 3656-3657.
[22] 谢祥红,段峰.血清25(OH)D_3,IgE及IL-10表达水平对婴幼儿呼吸道合胞病毒毛细支气管炎的诊断价值[J]. 武警医学,2020,31(10):895-897.
[23] 胡学亭, 李五娟, 牵晓营, 等. 肺炎支原体肺炎患儿补体及免疫球蛋白检测及临床分析[J].中国当代儿科杂志,2009,11(11):933-934.
[24] Josephs D H, Spicer J F, Corrigan C J, et al. Epidemiological associations of allergy, IgE and cancer[J]. Clin Exp Allergy, 2013, 43(10): 1110-1123.
[25] Sherman P W, Holland E, Sherman J S. Allergies: their role in cancer prevention[J]. Q Rev Biol, 2008, 83(4): 339-362.
[26] Josephs D H, Spicer J F, Corrigan C J, et al. Anticancer proinflammatory effects of an IgE antibody targeting the melanoma-associated antigen CSPG4[J]. Nat Commun, 2023, 14(1): 1877.
[27] Qiu B, Matthay K K. Advancing therapy for neuroblastoma[J]. Nat Rev Clin Oncol, 2022, 19: 515-533.
[28] Peyam srinivasan; bansal deepak neuroblastoma stage 4S (MS): identification of risk factors and treatment decisions[J].Indian J of Pediat,2023,2:213-214.
[29] 冯智博,唐希阳,吕垚,等. IGSF11:肿瘤免疫治疗新靶点[J]. 中国肺癌杂志,2025,28 (5):371-378.
[30] Yang Y,Wang S,Cai J,et al.Targeting ARHGEF12 promotes neuroblastoma differentiation, MYCN degradation, and reduces tumorigenicity[J].Dordrecht,2023,18:1871-1872.